|
1
|
Comparison of isotope ratio mass spectrometry and nondispersive isotope-selective infrared spectroscopy for 13C-urea breath test.
|
Am J Gastroenterol
|
1999
|
1.50
|
|
2
|
Circadian pattern of intragastric acidity in patients with non-erosive reflux disease (NERD).
|
Aliment Pharmacol Ther
|
2003
|
1.44
|
|
3
|
Normal values of 24-h ambulatory intraluminal impedance combined with pH-metry in subjects eating a Mediterranean diet.
|
Dig Liver Dis
|
2006
|
1.26
|
|
4
|
The impact of antibiotic resistance on the efficacy of three 7-day regimens against Helicobacter pylori.
|
Aliment Pharmacol Ther
|
2000
|
1.02
|
|
5
|
Effect of gastric acid suppression on 13C-urea breath test: comparison of ranitidine with omeprazole.
|
Aliment Pharmacol Ther
|
2000
|
0.93
|
|
6
|
An evaluation of the antireflux properties of sodium alginate by means of combined multichannel intraluminal impedance and pH-metry.
|
Aliment Pharmacol Ther
|
2005
|
0.89
|
|
7
|
Comparable Helicobacter pylori eradication rates obtained with 4- and 7-day rabeprazole-based triple therapy: a preliminary study.
|
Dig Liver Dis
|
2003
|
0.84
|
|
8
|
Eradication of Helicobacter pylori may reduce disease severity in rheumatoid arthritis.
|
Aliment Pharmacol Ther
|
2002
|
0.82
|
|
9
|
Helicobacter pylori infection is not involved in the pathogenesis of either erosive or non-erosive gastro-oesophageal reflux disease.
|
Aliment Pharmacol Ther
|
2003
|
0.82
|
|
10
|
Comparison of the main oesophageal pathophysiological characteristics between short- and long-segment Barrett's oesophagus.
|
Aliment Pharmacol Ther
|
2002
|
0.80
|
|
11
|
Carditis in patients with gastro-oesophageal reflux disease: results of a controlled study based on both endoscopy and 24-h oesophageal pH monitoring.
|
Aliment Pharmacol Ther
|
2004
|
0.78
|
|
12
|
Optimal duration of therapy combining ranitidine bismuth citrate with clarithromycin and metronidazole in the eradication of Helicobacter pylori infection.
|
Aliment Pharmacol Ther
|
1999
|
0.76
|
|
13
|
A study of 4- and 7-day triple therapy with rabeprazole, high-dose levofloxacin and tinidazole rescue treatment for Helicobacter pylori eradication.
|
Aliment Pharmacol Ther
|
2006
|
0.76
|